Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1680 of 5804
-
Can a drug combo shrink liver tumors enough for surgery?
Disease control CompletedBACKGROUND: For patients with liver-limited metastatic colorectal cancer (mCRC), complete resection of liver metastases is the only potentially curative treatment. The current goal of medical treatment for colorectal cancer with initially unresectable liver metastases is to maxi…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
One-Shot radiation hope for bulky tumors
Symptom relief Recruiting nowPalliative radiation therapy represents 40% of the on-going radiation at the Jewish General Hospital. In a traditional palliative radiation treatment to bulky or radioresistant tumors, radiotherapy schema varies from 24 to 30 Gys given in 3 to 10 fractions, depending on the tumor…
Phase: NA • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Can we predict who will relapse after brain inflammation?
Knowledge-focused CompletedThis study focuses on a rare brain disease called anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis. In this condition, the body's immune system mistakenly attacks a protein in the brain, which can cause problems with memory, thinking, behavior, and seizures. While most …
Sponsor: Shen Chun-Hong • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can a simple score prevent unnecessary hospital stays for chest pain?
Knowledge-focused CompletedChest pain remains one of the most common, potentially serious presenting complaints for adults emergency department visits with approximately 7.6 million yearly visits in the united states. The priority for emergency physician is to determine whether these patients with acute ch…
Sponsor: University of Monastir • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Radiation's hidden toll on the brain: new study maps cognitive changes to protect patients
Knowledge-focused Recruiting nowIn this proposal, the investigators introduce a novel, translational study to prospectively examine primary brain tumor patients undergoing fractionated radiation therapy to the brain. Quantitative neuroimaging, radiation dose information, and directed neurocognitive testing will…
Sponsor: Jona Hattangadi-Gluth • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New diabetes combo shows promise in japanese study
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of co-administration of Teneligliptin (MP-513) and Canagliflozin (TA-7284) once daily for 24 weeks in Japanese patients with Type 2 diabetes mellitus who are receiving treatment with Teneligliptin and have inadequat…
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New vaccine aims to fight childhood brain tumors without surgery
Disease control Recruiting nowThe study will assess the immunogenicity, safety and preliminary clinical efficacy of the glioma associated antigen (GAA)/tetanus toxoid (TT) peptide vaccine and poly-ICLC in HLA-A2+ children with unresectable low-grade gliomas that have received at least two chemotherapy/biologi…
Phase: PHASE2 • Sponsor: James Felker • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Lung cancer breakthrough: chemo spares Low-Risk patients
Knowledge-focused CompletedBrief Summary The goal of this clinical trial is to evaluate the effect of postoperative adjuvant chemotherapy (ACT) in patients with stage I non-squamous non-small cell lung cancer (NSCLC) after curative resection. The main questions it aims to answer are: Does ACT improve rec…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Frozen hope: new study protects fertility in young cancer patients
Knowledge-focused Recruiting nowBackground: Due to the remarkable improvement in treatments these last decades, long term survival can be expected in more than 80% of childhood cancer patients. Unfortunately, cancer treatments can be harmful to the gonads and can affect reproductive and endocrine functions. Wh…
Phase: NA • Sponsor: Gumy-Pause Fabienne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Promising combo tackles tough blood cancers in early trial
Disease control CompletedTo evaluate the safety and preliminary efficacy of acalabrutinib in combination with obinutuzumab in 4 separate cohorts of participants.
Phase: PHASE1 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New IV drug shows promise for kids with stubborn arthritis
Disease control CompletedThe purpose of this study is to evaluate the pharmacokinetics (the study of the way a drug enters and leaves the blood and tissues over time) of golimumab administered intravenously (IV) to pediatric participants with polyarticular (affects 5 or more joints) juvenile (an onset be…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New drug combo shows promise for Hard-to-Treat blood cancers
Disease control CompletedThis study is evaluating the safety, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy acalabrutinib and ACP 319 in B-cell malignancies.
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Sperm Pre-Treatment may boost IVF success and cut miscarriages
Disease control CompletedIntroduction To get through the egg vestment and fertilize the oocyte, the spermatozoon uses its acrosomal enzymes. When Intracytoplasmic sperm microinjection (ICSI) is performed, the acrosomal enzymes are introduced with the spermatozoa inside the ooplasme. The fate of these en…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Nutrition showdown: can cyclic feeding keep Crohn's at bay in kids?
Disease control CompletedThe purpose of this study is to compare the rate of first relapse at 12 months between maintenance therapy with cyclic exclusive enteral nutrition (EEN) (at least 100% daily calories) and maintenance therapy with supplementary enteral nutritional support (25% daily calories).
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Precision radiation may boost second stem cell transplants for relapsed blood cancers
Disease control TerminatedThis phase I trial studies the side effects and the best dose of intensity modulated total marrow irradiation (IMTMI) when given together with fludarabine phosphate and melphalan in treating patients with cancers of the blood (hematologic) that have returned after a period of imp…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New combo shows promise for Hard-to-Treat lymphoma
Disease control CompletedThis research study is evaluating a drug combination called Imprime PGG and Rituximab as a possible treatment for relapsed/refractory indolent B cell non-Hodgkin lymphomas (NHL).
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Keyhole surgery for stomach cancer: faster recovery or not?
Disease control CompletedThis is the first randomized controlled trial comparing laparoscopic and open gastrectomy for resectable gastric cancer in a Western population. The hypothesis is that laparoscopic gastrectomy will result in a lower post-operative burden by means of shorter post-operative hospita…
Phase: NA • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
HIV patients may ditch one drug without losing viral control
Disease control CompletedIn the early 2000s, the "TRILEGE©" study was realized to determine if the reductive anti retroviral strategy from an initial triple therapy (based on a protease inhibitor as the third agent) towards a dual therapy of nucleoside analogs (in particular the association of "zidovudin…
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Radiation plus pills may slow spread of advanced lung cancer
Disease control CompletedThis research study is studying a type of radiation therapy called Stereotactic Body Radiation Therapy (SBRT) as a possible treatment for stage IV non-small cell lung cancer (NSCLC) that has a mutated epidermal growth factor receptor (EGFR) or or displaced anaplastic lymphoma rec…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Turmeric compound tested to keep Crohn's at bay after surgery
Prevention CompletedCurcumin, the active ingredient of turmeric, has been used for long term in the treatment of inflammatory conditions. Inhibition of NF-κB is postulated as the main mechanism responsible for the anti-inflammatory effect of curcumin Aim : to study the effect of curcumin, 3g per da…
Phase: PHASE3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC